June 17, 2025 1 min watch Add subject to e mail alerts Obtain an e…
Read More
FDA approves pembrolizumab for resectable head and neck most cancers with PD-L1 expression
Credit score: Unsplash/CC0 Public Area Pembrolizumab, an immune checkpoint inhibitor, has been authorised by the U.S. Meals and Drug Administration…
Read More
